Latest Filings

Issuer Activity

Insider Overview :: Verisante Technology, Inc. (V:VRS) [?]
Business Focus: Advanced Medical Equipment & Technology Share on StockTwits
Log in or sign up for a free account to add this stock to your watch list.

Holdings trends & enhanced charts available in PDF report. Click here for details »
Latest 10 SEDI filings (by transaction date) for VRS within the last 6 months [?]
Amended Filing
As of 11:59pm ET July 21st, 2014
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
No SEDI filings within the past 6 months or filings data currently unavailable.
Sign up for an account or login above to see all SEDI filings within the past 6 months.
Latest 10 SEDI filings (by filing date) for VRS within the last 6 months [?]
Amended Filing
As of 11:59pm ET July 21st, 2014
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
No SEDI filings within the past 6 months or filings data currently unavailable.
Sign up for an account or login above to see all SEDI filings within the past 6 months.
Sign up for an account or login above to see the past 6 months of SEDI filings sorted by insider.
No Markers (TSX Insider Summaries) for VRS on July 21, 2014 [?]
To view marker data for the past week, sign up for an account or log in above.
To view more history, sign up for an account at inkresearch.com
Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology
 
See Regulatory Filings on SEDAR
Key People
Thomas A. Braun
President, Chief Executive Officer, Chief Business Development Officer, Director
Anna Trinh
Chief Financial Officer, Vice President - Administration, Corporate Counsel, Secretary
 
Company Contact
Address: Suite 306, 2309 West 41st Avenue
VANCOUVER BC V6M 2A3
Tel: N/A
Website: www.verisante.com
IR: www.verisante.com/invest
Business Overview
Verisante Technology, Inc. is a medical device company. The Company is engaged in commercializing systems for the early detection of cancer. The Company's product portfolios include Verisante Aura and Verisante Core. Verisante Aura is a non-invasive Raman spectroscopy system designed to aid medical professionals in the detection of skin cancer. The system provides valuable information by identifying spectral changes associated with the biochemistry of skin cancer cells in less than a second; providing immediate results. The Verisante Core series utilizes the platform technology behind the Verisante Aura for the early detection of other cancers including lung, colon and cervical, using an endoscopic attachment.
Financial Overview
For the three months ended 31 March 2014, Verisante Technology Inc revenues decreased 83% to C$40K. Net loss decreased 12% to C$1M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Stock based compensation decrease of 78% to C$30K (expense), Promotional costs decrease of 77% to C$21K (expense).
Employees: 8 as of Mar 31, 2009
Reporting Currency: Canadian Dollars
Enterprise value: $13.77M as of Mar 31, 2014
Annual revenue (TTM): $0.58M as of Mar 31, 2014
EBITDA (TTM): -$3.67M as of Mar 31, 2014
Net annual income (TTM): -$4.76M as of Mar 31, 2014
Free cash flow (TTM): -$3.01M as of Mar 31, 2014
Net Debt Last Fiscal Year: N/A
Shares outstanding: 83,698,117 as of Jun 27, 2014
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization
Competitors with Recent Insider Filings
Neovasc (T:NVC)
Zecotek Photonics (V:ZMS)
IMRIS (T:IM)
 
Verisante Technology, Inc. Insider Report Only $20.00